November saw a strong performance from all of our tactical portfolios, our growth portfolio rose 0.9% vs the median growth fund of 0.3%, and our Accumulation and Income portfolios rose 1% as bond markets recovered their losses from the prior months. Stock markets remained strong.

October was not our month. Stock markets pulled back but rebounded mid-month to end in the black on the back of encouraging corporate earnings and an easing of fears around China’s property sector. Our core portfolios underperformed as the market took a wait-and-see approach on our over-weight ...

September saw stock markets pull back as issues around growth and inflation hit markets. Our core portfolios performed much better than markets, our core Australian portfolio was flat vs the Australian market down 2%. Our core International fell 2% vs the MSCI World down 3%.

August was another strong month for the stock market. Our tactical portfolios performed well, Growth led the way up 2.9% over the month. We spoke last month about selling Australian stocks into the rallies, believing there will be a slow down in the next few months led by China and so far in ...

July was another strong month for the stock market. Our tactical portfolios performed well, up between 1.7% and 2.6% over the month. And August has been more of the same. We have been selling Australian stocks into the rallies, believing there will be a slow down in the next few months led by ...

June was another strong month for the stock market. Our tactical portfolios performed well, up between 0.9% and 2.1% over the month. On the one hand, we timed the rotation out of value stocks and into quality stocks well; the inflation fears that were so prevalent a few weeks ago have faded as our ...

The market seems to be oscillating between value and growth months. In May it was the turn of value portfolios (including ours) to outperform. Our direct equity portfolios beat benchmarks by over 1% on the month and our tactical asset portfolios finished up between 1% and 2.7%.

April continued the March boom, with the US leading the way, buoyed by a swift vaccine roll-out and fiscal stimulus measures. Investor sentiment was supported by the combined economic and policy backdrops, but also a robust US earnings season.

March was a month for value stocks to shine. Global markets boomed, up 5% and Australian markets rose 2.4%. We had positioned our portfolios for a rise in bond yields and a rotation to value stocks and so our portfolios outperformed benchmarks. Our asset allocation portfolios all rose as well, our ...

After a short-squeeze distraction in January, February saw the attention back on fundamentals: corporate earnings, economic data, and interest rates. Global equity markets closed the month with positive returns, despite end-of-month inflation concerns. The rotation to value stocks continued at the ...